|
Balance Sheet for
Gamma Pharmaceuticals Inc.
(GMPM)
|
|
|
|
|
|
|
| Assets
[+]
|
in Thousands of Dollars |
|
|
| Cash and Equivalents |
- |
117 |
71 |
161 |
116 |
| Restrictable Cash |
- |
- |
- |
- |
- |
| Marketable Securities |
- |
- |
- |
- |
- |
| Accounts Receivable |
10 |
10 |
47 |
- |
- |
| Loans Receivable |
- |
- |
- |
- |
- |
| Other Receivables |
- |
- |
- |
- |
- |
| Receivables |
10 |
10 |
47 |
- |
- |
| Inventories, Raw Materials |
- |
13 |
29 |
- |
- |
| Inventories, Work in Progress |
- |
17 |
92 |
- |
- |
| Inventories, Purchased Components |
- |
- |
- |
- |
- |
| Inventories, Finished Goods |
- |
112 |
7 |
- |
- |
| Inventories, Other |
142 |
- |
- |
7 |
- |
| Inventories, Adjustments & Allowances |
- |
- |
- |
- |
- |
| Inventories |
142 |
142 |
128 |
7 |
- |
| Prepaid Expenses |
- |
- |
38 |
24 |
7 |
| Current Deferred Income Taxes |
- |
- |
- |
- |
- |
| Other Current Assets |
(152) |
N/A |
- |
- |
- |
| Total Current Assets |
- |
269 |
285 |
192 |
122 |
| Land and Improvements |
- |
- |
- |
- |
- |
| Buildings and Improvement |
- |
- |
- |
- |
- |
| Machinery, Furniture and Equipment |
- |
27 |
25 |
3 |
- |
| Construction in Progress |
- |
- |
- |
- |
- |
| Fixed Assets, Other |
- |
- |
- |
- |
- |
| Fixed Assets, Total |
- |
27 |
25 |
3 |
- |
| Gross Fixed Assets |
- |
27 |
25 |
3 |
- |
| Accumulated Depreciation |
- |
(16) |
(7) |
(0) |
- |
| Net Fixed Assets |
- |
12 |
18 |
2 |
- |
| Intangibles |
- |
6,032 |
6,605 |
5,983 |
- |
| Cost in Excess |
- |
- |
- |
- |
- |
| Non-Current Deferred Income Taxes |
- |
- |
- |
- |
- |
| Other Non-Current Assets |
6,312 |
6,043 |
- |
- |
- |
| Total Non-Current Assets |
6,312 |
6,043 |
6,623 |
5,985 |
- |
| Total Assets |
6,312 |
6,312 |
6,907 |
6,177 |
122 |
|
| Liabilities
[+]
|
in Thousands of Dollars |
|
|
| Accounts Payable |
- |
270 |
225 |
142 |
2 |
| Short Term Debt |
480 |
480 |
- |
- |
- |
| Notes Payable |
3 |
3 |
197 |
- |
- |
| Accrued Expenses |
- |
185 |
- |
- |
- |
| Accrued Liabilities |
- |
185 |
523 |
233 |
- |
| Deferred Revenues |
- |
- |
- |
- |
- |
| Current Deferred Income Taxes |
- |
- |
- |
- |
- |
| Other Current Liabilities |
(483) |
- |
- |
24 |
- |
| Total Current Liabilities |
- |
938 |
945 |
400 |
2 |
| Long Term Debt |
307 |
307 |
580 |
- |
- |
| Deferred Income Tax |
- |
- |
- |
- |
- |
| Other Non-Current Liabilities |
938 |
(0) |
- |
- |
- |
| Minority Interest |
- |
- |
- |
- |
- |
| Capital Lease Obligations |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Preferred Equity Outside Shareholders' Equity |
- |
- |
- |
- |
- |
| Total Non-Current Liabilities |
1,245 |
307 |
580 |
- |
- |
| Total Liabilities |
1,245 |
1,245 |
1,525 |
400 |
2 |
| Preferred Shareholder's Equity |
0 |
0 |
- |
- |
- |
| Common Shareholder's Equity |
5,067 |
5,067 |
5,382 |
5,777 |
120 |
| Common Par |
- |
23 |
17 |
12 |
44 |
| Additional Paid in Capital |
- |
15,197 |
11,900 |
8,114 |
252 |
| Cumulative Translation Adjustments |
- |
- |
- |
- |
- |
| Retained Earnings |
- |
(10,311) |
(6,405) |
(2,609) |
(175) |
| Treasury Stock |
- |
- |
- |
- |
- |
| Other Equity Adjustments |
- |
N/A |
(130) |
260 |
- |
| Total Capitalization |
5,374 |
5,374 |
5,963 |
5,777 |
120 |
| Total Equity |
5,067 |
5,067 |
5,382 |
5,777 |
120 |
| Total Liabilities & Shareholder's Equity |
6,312 |
6,312 |
6,907 |
6,177 |
122 |
| Cash Flow |
(3,906) |
(4,949) |
(3,451) |
(2,353) |
(84) |
| Working Capital |
- |
(669) |
(660) |
(207) |
120 |
| Free Cash Flow |
(1,161) |
N/A |
(1,437) |
(672) |
(92) |
| Invested Capital |
- |
5,857 |
5,963 |
5,777 |
120 |
| Shares Outstanding - Common Class Only |
- |
N/A |
16,759 |
12,382 |
14,234 |
| Preferred Shares Outstanding |
- |
7 |
- |
- |
- |
| Total Ordinary Shares |
- |
22,538 |
- |
- |
- |
| Total Common Shares Outstanding |
- |
N/A |
16,759 |
12,382 |
14,234 |
| Treasury Shares |
- |
- |
- |
- |
- |
| Basic Weighted Shares Outstanding |
- |
18,704 |
13,796 |
10,761 |
44 |
| Diluted Weighted Shares Outstanding |
- |
18,704 |
13,796 |
10,761 |
44 |
|
|
|